Martínez-Canales S; Cifuentes F; De Rodas Gregorio ML; Serrano-Oviedo L; Galan-Moya EM; Amir E; Pandiella A; Győrffy, Balázs; Ocaña A
(2017)
Background: Most patients with early stage triple negative breast cancer (TNBC) receive adjuvant chemotherapy. Activation of the immune system is associated with tumor response and may help identify TNBC with favorable ...